Navigation Links
Amicus Therapeutics Announces Second Quarter 2009 Financial Results
Date:8/5/2009

8,848 13,470 15,789 25,345 152,987 General and administrative 5,118 5,223 10,305 10,419 68,154 Impairment of leasehold improvements - - - - 1,030 Depreciation and amortization 332 519 653 1,024 5,311 In-process research and development - - - - 418 Total operating expenses 14,298 19,212 26,747 36,788 227,900 Loss from operations (10,491) (13,851) (19,779) (26,819) (201,181) Other income (expenses): Interest income 1,331 269 3,034 795 13,555 Interest expense (59) (41) (129) (71) (1,718) Change in fair value of warrant liability - - - - (454) Other expense - - - - (1,180) Loss before tax benefit (9,219) (13,623) (16,874) (26,095) (190,978) (Provision for)/ benefit from income taxes (75) - (150) - 695 Net loss (9,294) (13,623) (17,024) (26,095) (190,283) Deemed dividend - - - - (19,424) Preferred stock accretion - - - - (802) Net loss attributable to common stockholders $(9,294) $(13,623) $(17,024) $(26,095)$(210,509) Net loss attributable to common stockholders per common share - basic and diluted $(0.41) $(0.60) $(0.76) $(1.15) Weighted-average common shares outstanding - basic and diluted 22,467,198 22,618,026 22,439,893 22,615,951


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 From smart street lighting to ... in enabling success in dealing with important Societal Challenges ... helped bring focus to the role and further potential ... annual meeting last week in Brussels. SPIE ... 28 and 29 May at the Hotel Le Plaza. ...
(Date:6/2/2015)... TORONTO , June 2, 2015 /PRNewswire/ - Aptose ... clinical-stage company developing new therapeutics that target the underlying ... and Drug Administration (FDA) has granted the company orphan ... myeloid leukemia (AML). APTO-253, a first-in-class inducer of the ... a Phase Ib clinical trial in patients with AML, ...
(Date:6/2/2015)... Tauriga Sciences, Inc. (OTCQB:  TAUG) ("Tauriga" or ... interests in the natural wellness sector and in ... announced that it has officially extinguished all further ... for a one-time cash payment of $230,000 USD.  ... entered into a Settlement Agreement (the "Settlement Agreement") ...
(Date:6/2/2015)... -- Meet ARGUS, The World,s First Contactless ... People. Analyze emotions and predict actions. Explore a New ... first Responsive-RPG: "The Eye: Genesis".      (Photo: ... , https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 Imagine ... feelings - and those of others. Being able to ...
Breaking Biology Technology:Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 3Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 4ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3
... who venture into the conference room at Neohapsis, Inc. ... depicting Kelly Hansen as an entrepreneurial superhero. Created by ... the poster is located at Milwaukee's Discovery World Museum. ... Hall of Entrepreneurs because of the tremendous obstacles Hansen has ...
... Jim Doyles effort to keep Wisconsins five military installations off ... not just because those bases bring nearly $850 million per ... fortress of ideas and materials to be used in the ... attention of national security policymakers. , ,Doyle toured state military ...
... S&C Bank-Eau Claire has made a gift ... Schneider Social Science Hall at the University of Wisconsin-Eau ... S&C Bank gift to the UW-Eau Claire Foundation ... Excellence, the foundation's ongoing campaign for the university's people and ...
Cached Biology Technology:Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 2Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 3Wisconsins untapped defense might: why saving military bases is just a start 2Wisconsins untapped defense might: why saving military bases is just a start 3UW-Eau Claire receives $35,000 remodeling gift 2
(Date:5/18/2015)... 18, 2015 Fingerprint Cards (FPC) has ... FPC1145, FPC1155 and FPC1035 from one if its module partners. ... including Q3 2015 and the sensors will be used by ... values for 2015 hereby amount to 740 MSEK to date. ... 140 MSEK and a number of smaller orders not separately ...
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/10/2015)... May 11, 2015 Fingerprint Cards (FPC) ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... used by smartphone manufacturers in China . ... communicated revenue guidance of + 1 000 MSEK for 2015.   ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... Conservation Society, the ARC Centre of Excellence for ... that the fishing villages of Madagascara country with ... of fishing regulations, an encouraging finding that bodes ... in the island nation. Specifically, Malagasy ...
... This news release is available in German . ... respect: Even after repeated contact with dirt and dust do their ... the Carnegie Mellon University, Pittsburgh, have now developed the first adhesive ... as the toes of a gecko, but also possesses similar self-cleaning ...
... insects. As such, they are relatively well studied, especially ... are explored most thoroughly. First eastern US butterfly species ... Carl Linnaeus himself, over 250 years ago. For ... been cataloguing species diversity of eastern butterflies, and every ...
Cached Biology News:Surveys find that despite economic challenges Malagasy fishers support fishing regulations 2Surveys find that despite economic challenges Malagasy fishers support fishing regulations 3Gecko-inspired adhesion: Self-cleaning and reliable 2Two new butterfly species discovered in eastern USA 2
Rabbit polyclonal to BCA1 ( Abpromise for all tested applications). Antigen: Generated using E.coli expressed mouse BCA1. Entrez GeneID: 10563 SWISS Protein ID: O43927...
SH3 Proteins II Sampler Kit 10g each...
Tumor Suppressor Sampler Kit 10 mu g each...
Human peripheral blood eosinophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Biology Products: